why choose us

First received: November 22, 2024

Clinical Trial: A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Drug-Drug Interaction, Single-arm, Open-label Study to Assess the Effect of Quinidine on the Pharmacokinetics of Orforglipron in Healthy Participants

Brief Summary: The purpose of this study is to determine the effect of quinidine on the levels of orforglipron in the blood stream and how long it takes the body to eliminate it, when administered orally in healthy participants.The study will last up to approximately 8 weeks including screening.

Read more